[HLFG] QoQ Cumulative Quarter Result on 31-Mar-2016 [#3]

Announcement Date
24-May-2016
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2016
Quarter
31-Mar-2016 [#3]
Profit Trend
QoQ- 48.45%
YoY- -18.15%
View:
Show?
Cumulative Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 2,535,915 1,181,462 4,543,328 3,336,831 2,311,652 1,146,622 4,490,944 -31.56%
PBT 1,558,008 725,514 2,565,038 1,776,230 1,184,335 696,979 3,023,285 -35.59%
Tax -310,905 -142,154 -501,494 -313,204 -206,251 -115,300 -562,908 -32.56%
NP 1,247,103 583,360 2,063,544 1,463,026 978,084 581,679 2,460,377 -36.29%
-
NP to SH 829,225 386,192 1,358,895 965,398 650,331 386,882 1,620,743 -35.90%
-
Tax Rate 19.96% 19.59% 19.55% 17.63% 17.41% 16.54% 18.62% -
Total Cost 1,288,812 598,102 2,479,784 1,873,805 1,333,568 564,943 2,030,567 -26.04%
-
Net Worth 16,179,988 15,916,059 15,399,676 15,158,698 14,074,607 13,787,257 13,108,795 14.99%
Dividend
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Div 149,177 149,177 436,056 436,056 140,206 136,299 399,146 -47.95%
Div Payout % 17.99% 38.63% 32.09% 45.17% 21.56% 35.23% 24.63% -
Equity
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Net Worth 16,179,988 15,916,059 15,399,676 15,158,698 14,074,607 13,787,257 13,108,795 14.99%
NOSH 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 1,048,460 1,050,384 6.04%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin 49.18% 49.38% 45.42% 43.84% 42.31% 50.73% 54.79% -
ROE 5.13% 2.43% 8.82% 6.37% 4.62% 2.81% 12.36% -
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 220.99 102.96 395.93 290.79 214.34 109.36 427.55 -35.46%
EPS 72.50 33.80 123.20 88.60 61.20 36.90 154.30 -39.42%
DPS 13.00 13.00 38.00 38.00 13.00 13.00 38.00 -50.92%
NAPS 14.10 13.87 13.42 13.21 13.05 13.15 12.48 8.43%
Adjusted Per Share Value based on latest NOSH - 1,147,516
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 220.99 102.96 395.93 290.79 201.45 99.92 391.36 -31.56%
EPS 72.50 33.80 123.20 88.60 56.67 33.71 141.24 -35.76%
DPS 13.00 13.00 38.00 38.00 12.22 11.88 34.78 -47.95%
NAPS 14.10 13.87 13.42 13.21 12.2653 12.0149 11.4236 14.99%
Price Multiplier on Financial Quarter End Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 -
Price 14.22 15.42 14.68 15.52 13.96 14.00 15.16 -
P/RPS 6.43 14.98 3.71 5.34 6.51 12.80 3.55 48.32%
P/EPS 19.68 45.82 12.40 18.45 23.15 37.94 9.83 58.51%
EY 5.08 2.18 8.07 5.42 4.32 2.64 10.18 -36.95%
DY 0.91 0.84 2.59 2.45 0.93 0.93 2.51 -48.99%
P/NAPS 1.01 1.11 1.09 1.17 1.07 1.06 1.21 -11.29%
Price Multiplier on Announcement Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 21/02/17 22/11/16 29/08/16 24/05/16 23/02/16 17/11/15 26/08/15 -
Price 15.20 15.10 16.10 14.92 14.14 13.70 13.22 -
P/RPS 6.88 14.67 4.07 5.13 6.60 12.53 3.09 70.09%
P/EPS 21.03 44.87 13.60 17.73 23.45 37.13 8.57 81.43%
EY 4.75 2.23 7.36 5.64 4.26 2.69 11.67 -44.92%
DY 0.86 0.86 2.36 2.55 0.92 0.95 2.87 -55.05%
P/NAPS 1.08 1.09 1.20 1.13 1.08 1.04 1.06 1.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment